This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Pathophysiology

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

There are three components to the airway limitation in asthma:

  • bronchoconstriction - contraction of bronchial smooth muscle. This is the acute phase of an asthma attack, and time of onset is in minutes
  • mucosal oedema; and
  • increased secretion of tenacious mucous are features of the late phase which is mediated by mast cells and macrophages. These release chemotactic factors which attract further immune system cells and compound the inflammatory reaction

In fatal cases of asthma autopsy may reveal various chronic pathological features in the bronchial wall:

  • eosinophilic infiltration
  • an increase in number of goblet cells
  • viscid mucus due to inflammatory protein leak, containing eosinophils, plugging bronchi
  • thickening of the epithelial basement membrane
  • there may be hypertrophy of bronchial muscle

The lungs themselves may be overinflated but otherwise normal.

These features may be found to a minor degree in patients with apparently well-controlled asthma.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.